(Q40526970)

21 September 2017

title

Immunogenecity of synthetic peptides representing linear B-cell epitopes of VapA of Rhodococcus equi (English)

1 reference

21 September 2017

Rhodococcus equi

1 reference

Saïd Taouji

1

1 reference

21 September 2017

Izumi Nomura

2

1 reference

21 September 2017

Steeve Giguère

3

1 reference

21 September 2017

Seiji Tomomitsu

4

1 reference

21 September 2017

Tsutomu Kakuda

5

1 reference

21 September 2017

Vincent Ganne

6

1 reference

21 September 2017

Shinji Takaï

7

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

22

1 reference

21 September 2017

issue

9-10

1 reference

21 September 2017

page(s)

1114-1123

1 reference

Assessment of the immunogenic potential of Rhodococcus equi virulence associated protein (VapA) in mice

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Live virulent Rhodococcus equi, rather than killed or avirulent, elicits protective immunity to R. equi infection in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Partial correction of the TH2/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

The expanding universe of T-cell subsets: Th1, Th2 and more.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Induction of protective CTL responses in newborn mice by a murine retrovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Pathogenesis and virulence of Rhodococcus equi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Protective effect against Rhodococcus equi infection in mice of IgG purified from horses vaccinated with virulence associated protein (VapA)-enriched antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

B-Cell epitope mapping of the VapA protein of Rhodococcus equi: implications for early detection of R. equi disease in foals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Serum and mucosal antibodies of infected foals recognized two distinct epitopes of VapA of Rhodococcus equi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Enhancement of the T cell response to a mycobacterial peptide by conjugation to synthetic branched polypeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. Structure and effect on macrophage cytokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Synthetic peptide vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Pathogenesis ofRhodococcus equiinfection in mice: Roles of virulence plasmids and granulomagenic activity of bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Serum and mucosal antibody isotype responses to M-like protein (SeM) of Streptococcus equi in convalescent and vaccinated horses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Immunity to Rhodococcus equi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Immunity to Rhodococcus equi: antigen-specific recall responses in the lungs of adult horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Regulation of cytokine gene expression by adjuvants in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

Identification of 15- to 17-kilodalton antigens associated with virulent Rhodococcus equi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.10.006

1 reference

21 September 2017

1 reference